3648 results for «2564»
3648 results
Pharmacotherapy coronary interventions: new insights
22 May 2025 – From EuroPCR 2025
Stay abreast of new insights in pharmacotherapy for coronary interventions with a focus on optimizing patient outcomes. Topics include ticagrelor monotherapy in chronic coronary syndrome post-PCI, analysis of multiple events in high bleeding risk patients from the MASTER DAPT trial, effects of beta-blocker interruption in MI...
Management of complex left main trifurcation lesion
22 May 2025 – From EuroPCR 2025
This session focuses on the management of complex left main trifurcation lesions. Review hybrid and double TAP techniques, long-term follow-up outcomes, and innovative approaches such as the inverted double TAP technique, offering insights into optimizing treatment strategies for these challenging anatomical scenarios.
Optimal use of cardiac imaging to plan and guide transcatheter LAA closure
22 May 2025 – From EuroPCR 2025
Optimize left atrial appendage (LAA) closure outcomes through expert use of cardiac imaging. This session details the role of various imaging modalities in pre-procedural planning, intraprocedural guidance, and post-procedural assessment. Gain practical insights on transesophageal echocardiography, computed tomography, intracardiac echocardiography, and their integration to enhance procedural...
Challenging tricuspid TEER cases
22 May 2025 – From EuroPCR 2025
Explore challenging tricuspid transcatheter edge-to-edge repair (TEER) cases highlighting combined LAA occlusion and mitral valve repair, anatomical complexities, and strategies to complete surgical interventions percutaneously. Discuss the balance between procedural perfection and clinical practicality in complex valve anatomies.
TAVI outcomes
22 May 2025 – From EuroPCR 2025
Examine contemporary outcomes of transcatheter aortic valve implantation (TAVI) across diverse patient populations and device generations. This session presents data on severe aortic stenosis stratified by resting gradient, comparisons between bicuspid and tricuspid valve stenosis, and clinical results of intra-annular versus supra-annular devices, including two-year outcomes...
Troubleshooting and management communication in LAA closure
22 May 2025 – From EuroPCR 2025
This session provides comprehensive guidance on troubleshooting and communication during left atrial appendage (LAA) closure procedures. Covering device migration management, transeptal puncture in high bleeding risk patients, scoliosis adaptations, and advanced catheter techniques, it emphasizes practical solutions for procedural complications.
Coronary physiology: FFR and beyond
22 May 2025 – From EuroPCR 2025
Advance your understanding of coronary physiology with a focus on fractional flow reserve (FFR) and beyond. This session covers randomized trials comparing physiology-guided treatment to standard care in ANOCA, graft patency related to quantitative flow ratio, impacts of microvascular dysfunction on patient outcomes, and prognostic value...
Clinical impact of mechanical circulatory support
22 May 2025 – From EuroPCR 2025
Explore the clinical impact of mechanical circulatory support through a series of detailed presentations covering protocols and training effects on outcomes in left-sided micro-axial flow-supported shock patients, practice variations between Sweden and the U.S., six-month outcomes post coronary intervention with VA-ECMO, and the prognostic value of...
All you need to know on aorto iliac disease during TAVI: from access to complications management
22 May 2025 – From EuroPCR 2025
Gain expertise in managing aorto-iliac disease during TAVI procedures, from access planning to complication management. This session covers key imaging techniques, decision-making regarding stenting and lesion modification, approaches to access-related complications, and criteria for involving vascular surgeons, ensuring procedural safety and success.
ACS management: when imaging matters
22 May 2025 – From EuroPCR 2025
This session focuses on the critical role of intracoronary imaging in acute coronary syndrome (ACS) management. Topics include spontaneous coronary artery dissection (SCAD) cases, the utilization of IVUS and cardiac CT in emergent PCI during cardiogenic shock, and the assessment of non-culprit lesions using OCT to...
TAVI in bicuspid aortic valve disease
22 May 2025 – From EuroPCR 2025
Explore the unique challenges of TAVI in bicuspid aortic valve disease with a focus on long-term outcomes, residual gradients, prosthesis-patient mismatch, and anatomical subtype comparisons. This session draws on international registry data to inform clinical decision-making and optimize procedural strategies in this complex patient population.
Antiplatelet strategies for clinical dilemmas
22 May 2025 – From EuroPCR 2025
Dive into the complexities of antiplatelet strategies tailored for challenging clinical scenarios. This session covers antiplatelet therapy in myocardial bridge, bleeding risk reduction via ticagrelor removal before urgent CABG, peri-procedural management for patients on oral anticoagulants undergoing PCI, and the use of cangrelor in out-of-hospital cardiac...
Advanced tools for the diagnosis of coronary artery disease
22 May 2025 – From EuroPCR 2025
This session highlights advanced diagnostic tools for coronary artery disease, focusing on innovative pressure gradient assessments, computed tomography perfusion accuracy in stented patients, head-to-head comparisons of IQ-FFR with invasive FFR, and comprehensive evaluations of coronary physiology and plaque vulnerability derived from angiography.
Redefining the red flags: early detection of myocardial infarction in women
22 May 2025 – From EuroPCR 2025
Gain a unique patient-centered perspective on early myocardial infarction detection in women. This session features a survivor's story, collaborative step-by-step clinical approaches, and key aspects of cardiac rehabilitation, emphasizing shared decision-making to improve patient outcomes in complex cases.
TAVI in difficult scenarios: bicuspid anatomy and pure aortic regurgitation
22 May 2025 – From EuroPCR 2025
Address challenging TAVI scenarios involving bicuspid anatomy and pure aortic regurgitation with insights from international experiences. This session compares treatment options in China and Germany, explores anatomical and disease differences, and reviews various TAVI devices through detailed case presentations and expert commentary.
Novel tools and techniques to manage complex PCI scenarios
22 May 2025 – From EuroPCR 2025
This session introduces novel tools and techniques to manage complex PCI scenarios. Key topics include intravascular lithotripsy advancements for in-stent restenosis, innovative balloon-assisted fenestration of covered stents, long-term outcomes of drug-eluting balloons post directional coronary atherectomy, and safety and efficacy data on a novel high-pressure cutting...
Permanent pacing after TAVI
23 May 2025 – From EuroPCR 2025
Explore predictors and mechanisms leading to permanent pacemaker implantation after TAVI. This session reviews electrophysiological intervals, atrial pacing markers, anatomical risk factors, and outcomes associated with new generation transcatheter heart valves.
Best companion's case on intravascular lithotripsy
23 May 2025 – From EuroPCR 2025
Join this session focusing on intravascular lithotripsy in challenging cases, emphasizing device and drug synergy, IVUS guidance, and strategies to avoid exacerbating complications. Clinical cases demonstrate management of tough calcified lesions with novel approaches.
High-risk PCI in TAVI procedures
23 May 2025 – From EuroPCR 2025
This session highlights high-risk PCI in the context of TAVI procedures, including hybrid approaches for aortic stenosis with coronary disease, valve-in-valve scenarios, and unique anatomical challenges such as total situs inversus, emphasizing comprehensive patient management.
Out of the box: tackling complex peripheral intervention
23 May 2025 – From EuroPCR 2025
Explore unconventional approaches to complex peripheral interventions through case studies involving pulmonary arteriovenous malformations, splenic aneurysms, vascular complications post maxillofacial surgery, and cyanosis in structurally normal hearts, emphasizing diagnostic and therapeutic ingenuity.
